Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

Background<br/> Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Henriques, G, Phommasone, K, Tripura, R, Peto, T, Raut, S, Snethlage, C, Sambo, I, Sanann, N, Nguon, C, Adhikari, B, Pongvongsa, T, Imwong, M, von Seidlein, L, Day, N, White, N, Dondorp, A, Newton, P, Ley, B, Mayxay, M
פורמט:	Journal article
יצא לאור:	BioMed Central 2018

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

פריטים דומים